These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 7934594

  • 21. [A study of epidemiology and fetal effects of human parvovirus B19 infection].
    Oka H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jun; 45(6):533-9. PubMed ID: 8315312
    [Abstract] [Full Text] [Related]

  • 22. Pharmacological treatment of immune-mediated inner ear disorders. A clinical immunology and audiology survey.
    Veldman JE.
    Scand Audiol Suppl; 1986 Jun; 26():21-6. PubMed ID: 3472327
    [Abstract] [Full Text] [Related]

  • 23. [The diagnostic value of virus serology in patients with non-ischemic systolic heart failure and parvovirus B19 infection].
    Nowalany-Kozielska E, Kozieł M, Domal-Kwiatkowska D, Dworniczak S, Wojnicz R, Wojciechowska C, Jachec W, Kawecki D, Smolik S, Weglarz L, Kozielski J.
    Wiad Lek; 2012 Jun; 65(4):211-5. PubMed ID: 23654140
    [Abstract] [Full Text] [Related]

  • 24. Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins.
    Palmer P, Pallier C, Leruez-Ville M, Deplanche M, Morinet F.
    Clin Diagn Lab Immunol; 1996 Mar; 3(2):236-8. PubMed ID: 8991644
    [Abstract] [Full Text] [Related]

  • 25. Human parvovirus B19 and rheumatoid arthritis.
    Taylor HG, Borg AA, Dawes PT.
    Clin Rheumatol; 1992 Dec; 11(4):548-50. PubMed ID: 1486749
    [Abstract] [Full Text] [Related]

  • 26. Childhood idiopathic thrombocytopenic purpura: association with human parvovirus B19 infection.
    Murray JC, Kelley PK, Hogrefe WR, McClain KL.
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):314-9. PubMed ID: 7978048
    [Abstract] [Full Text] [Related]

  • 27. A school outbreak of parvovirus B19 infection investigated using salivary antibody assays.
    Rice PS, Cohen BJ.
    Epidemiol Infect; 1996 Jun; 116(3):331-8. PubMed ID: 8666078
    [Abstract] [Full Text] [Related]

  • 28. Parvovirus B19 infection and autoimmune disease.
    Lehmann HW, von Landenberg P, Modrow S.
    Autoimmun Rev; 2003 Jun; 2(4):218-23. PubMed ID: 12848949
    [Abstract] [Full Text] [Related]

  • 29. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
    Grosse-Bley A, Eis-Hübinger AM, Kaiser R, Oldenburg J, Brackmann HH, Schwarz TF, Schneweis KE.
    Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
    [Abstract] [Full Text] [Related]

  • 30. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies.
    Nigro G, Luzi G, Fridell E, Ferrara M, Pisano P, Gattinara GC, Mezzaroma I, Söderlund M, Rasnoveanu D, Aiuti F.
    AIDS; 1992 Jul; 6(7):679-84. PubMed ID: 1503687
    [Abstract] [Full Text] [Related]

  • 31. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
    Chehadeh W, Halim MA, Al-Nakib W.
    Virology; 2009 Jul 20; 390(1):56-63. PubMed ID: 19450862
    [Abstract] [Full Text] [Related]

  • 32. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay.
    Bostic JR, Brown KE, Young NS, Koenig S.
    J Infect Dis; 1999 Mar 20; 179(3):619-26. PubMed ID: 9952368
    [Abstract] [Full Text] [Related]

  • 33. Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niterói city area, State of Rio de Janeiro, Brazil).
    Oliveira SA, Camacho LA, Pereira AC, Faillace TF, Setubal S, Nascimento JP.
    Mem Inst Oswaldo Cruz; 2002 Oct 20; 97(7):965-70. PubMed ID: 12471422
    [Abstract] [Full Text] [Related]

  • 34. [Parvovirus B19 infection: the general aspects and gestational problems].
    Di Stefano L, Carta G, Barnabei R, Tomei E, Toro G, Moscarini M.
    Minerva Ginecol; 1995 Apr 20; 47(4):121-5. PubMed ID: 7644092
    [Abstract] [Full Text] [Related]

  • 35. Juvenile dermatomyositis in a child infected with human parvovirus B19.
    Lewkonia RM, Horne D, Dawood MR.
    Clin Infect Dis; 1995 Aug 20; 21(2):430-2. PubMed ID: 8562756
    [Abstract] [Full Text] [Related]

  • 36. Autoimmune inner ear disease: results of therapy.
    McCabe BF.
    Adv Otorhinolaryngol; 1991 Aug 20; 46():78-81. PubMed ID: 1927720
    [No Abstract] [Full Text] [Related]

  • 37. [Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report].
    Banno S, Matsumoto Y, Sugiura Y, Ueda R.
    Ryumachi; 1997 Aug 20; 37(4):581-6. PubMed ID: 9311285
    [Abstract] [Full Text] [Related]

  • 38. Autoimmune inner ear disease: steroid and cytotoxic drug therapy.
    Lasak JM, Sataloff RT, Hawkshaw M, Carey TE, Lyons KM, Spiegel JR.
    Ear Nose Throat J; 2001 Nov 20; 80(11):808-11, 815-6, 818 passim. PubMed ID: 11816893
    [Abstract] [Full Text] [Related]

  • 39. Parvovirus B19 Infection as a Rare Cause of Fulminant Liver Failure: A Case Report.
    Islek A, Keskin H, Agın M, Aksungur N, Korkut E, Ozturk G.
    Transplant Proc; 2019 May 20; 51(4):1169-1171. PubMed ID: 31101193
    [Abstract] [Full Text] [Related]

  • 40. Parvovirus B19 antibodies in sera of patients with unexplained exanthemata from Belém, Pará, Brazil.
    de Freitas RB, de Miranda MF, Shirley J, Tudor R, Desselberger U, Linhares AC.
    Mem Inst Oswaldo Cruz; 1993 May 20; 88(3):497-9. PubMed ID: 8107612
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.